AbCellera Biologics (ABCL) Prepaid Assets (2020 - 2026)
AbCellera Biologics filings provide 7 years of Prepaid Assets readings, the most recent being $98.1 million for Q1 2026.
- Quarterly Prepaid Assets rose 3.59% to $98.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $98.1 million through Mar 2026, up 3.59% year-over-year, with the annual reading at $111.1 million for FY2025, 65.49% up from the prior year.
- Prepaid Assets hit $98.1 million in Q1 2026 for AbCellera Biologics, down from $111.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $133.0 million in Q3 2025 and bottomed at $28.9 million in Q1 2022.
- Average Prepaid Assets over 5 years is $73.3 million, with a median of $67.1 million recorded in 2024.
- The largest annual shift saw Prepaid Assets skyrocketed 600.81% in 2022 before it crashed 43.01% in 2024.
- AbCellera Biologics' Prepaid Assets stood at $75.4 million in 2022, then dropped by 25.99% to $55.8 million in 2023, then grew by 20.3% to $67.1 million in 2024, then surged by 65.49% to $111.1 million in 2025, then decreased by 11.71% to $98.1 million in 2026.
- Per Business Quant, the three most recent readings for ABCL's Prepaid Assets are $98.1 million (Q1 2026), $111.1 million (Q4 2025), and $133.0 million (Q3 2025).